Metastatic Merkel Cell Carcinoma: Insights on the Clinical Application of Immune Checkpoint Inhibitors

This multifaceted program which includes a module interactive toxicity management algorithm tool summary resource guide and expert commentaries equips clinicians with evidence-based insights on how to incorporate immune checkpoint inhibitors into clinical management of patients with metastatic Merkel cell carcinoma.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

Supporters

This activity is supported by an educational grant from

Merck KGaA

Pfizer, Inc.